SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-014411
Filing Date
2019-11-21
Accepted
2019-11-21 17:07:34
Documents
14
Period of Report
2019-11-20
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K a8-kportola112019.htm   iXBRL 8-K 42358
  Complete submission text file 0001628280-19-014411.txt   185680

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptla-20191120.xsd EX-101.SCH 4663
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptla-20191120_cal.xml EX-101.CAL 699
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptla-20191120_def.xml EX-101.DEF 1549
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptla-20191120_lab.xml EX-101.LAB 26142
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptla-20191120_pre.xml EX-101.PRE 13655
14 EXTRACTED XBRL INSTANCE DOCUMENT a8-kportola112019_htm.xml XML 4298
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35935 | Film No.: 191238011
SIC: 2834 Pharmaceutical Preparations